CKD Stage Classification for GFR 47
GFR-Based Staging
- The American Journal of Kidney Diseases defines Stage 3a CKD as a GFR of 45-59 mL/min/1.73 m², which encompasses a patient's GFR of 47 mL/min/1.73 m² 1, 2, 3, 4
- The Kidney Disease: Improving Global Outcomes (KDIGO) and Kidney Disease Outcomes Quality Initiative (KDOQI) endorse the subdivision of Stage 3 CKD into 3a and 3b because mortality and adverse outcome risks vary greatly between these subgroups, making this distinction clinically important 1, 2
Complete CKD Classification Requirements
- The American Journal of Kidney Diseases and Diabetes Care recommend that CKD classification requires both GFR category AND albuminuria measurement to fully assess risk and guide treatment decisions 1, 4, 5
- The three albuminuria categories are: A1 (<30 mg/g creatinine), A2 (30-299 mg/g creatinine), and A3 (≥300 mg/g creatinine) 3, 5
- At GFR 47 with normal albuminuria (A1), the patient would be classified as G3a/A1, which represents moderate risk (yellow zone) requiring annual monitoring 4, 5
- If albuminuria is elevated to A2 or A3 levels, the risk increases substantially (orange to red zones), requiring more frequent monitoring (twice to three times yearly) and consideration for nephrology referral 4, 5
Clinical Implications at Stage 3a
- Medication dose adjustments are required at this GFR level, particularly for renally cleared drugs 2
- ACE inhibitors or ARBs are preferred antihypertensive agents if the patient has diabetes with hypertension and any degree of albuminuria 3
- Nephrology referral is recommended if there is severely increased albuminuria (A3 category), regardless of the GFR being in the 3a range 4, 5
- Annual monitoring of both eGFR and UACR is the minimum recommended frequency for patients at this stage without elevated albuminuria 3, 4